Carbapenems

Key Points

  • Carbapenems are broad-spectrum beta-lactam antibiotics that inhibit bacterial cell-wall synthesis.
  • They are typically reserved for life-threatening or multidrug-resistant infections, including complex hospital-acquired infections.
  • Cross-sensitivity can occur in clients with severe penicillin or cephalosporins allergy history.
  • Dosing requires caution and adjustment in renal impairment; monitor BUN, creatinine, and renal trend.
  • Monitor for GI effects, rash, pruritus, injection-site reactions, and superinfection findings such as C. diff and candidiasis.
  • Side effects may emerge or persist even after discontinuation, so delayed symptom reporting is important.

Mechanism of Action

Carbapenems are bactericidal beta-lactam antibiotics that inhibit bacterial cell-wall synthesis, leading to cell death. Their broad activity includes many gram-positive and gram-negative organisms.

Clinical Use

  • Serious multidrug-resistant infections.
  • Complex healthcare-associated infections.
  • Infections in immunocompromised clients when broad empiric coverage is required.

Common prototype reference in this source: imipenem (IV).

Nursing Considerations

  • Review allergy history before first dose, especially prior severe reactions to penicillins or cephalosporins.
  • Obtain culture data before initial therapy when ordered, then monitor culture results for ongoing regimen appropriateness.
  • Adjust dose for renal impairment and monitor renal function trend.
  • Use additional caution in clients with seizure disorders or renal dysfunction.
  • Monitor infection response markers: WBC trend, fever trend, and the actual infection site.

Side Effects and Adverse Effects

  • Common: nausea, vomiting, diarrhea, GI upset.
  • Other: injection-site reactions, rash, pruritus.
  • Important monitoring: C. diff risk, yeast superinfection signs, delayed adverse-effect pattern after discontinuation.

Health Teaching

  • Report loose or foul-smelling stool, vaginal itching/discharge, fever, or bloody diarrhea promptly.
  • Do not self-treat severe diarrhea without provider guidance.
  • Complete the prescribed course and follow-up labs/monitoring as instructed.
  • Report new symptoms even if they begin after therapy has ended.

Self-Check

  1. Why should carbapenems be used cautiously in clients with severe penicillin allergy history?
  2. Which assessment findings suggest carbapenem-related superinfection requiring escalation?
  3. What renal-monitoring pattern should trigger prompt reassessment of carbapenem dosing?